JP5858994B2 - 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 - Google Patents

口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 Download PDF

Info

Publication number
JP5858994B2
JP5858994B2 JP2013517583A JP2013517583A JP5858994B2 JP 5858994 B2 JP5858994 B2 JP 5858994B2 JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013517583 A JP2013517583 A JP 2013517583A JP 5858994 B2 JP5858994 B2 JP 5858994B2
Authority
JP
Japan
Prior art keywords
peg
polyethylene glycol
certain embodiments
weight
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013517583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530208A5 (enExample
JP2013530208A (ja
Inventor
ヴィティンス，ペーター
ランゲナウアー，マルセル
シェーラー，パウル，マルティン
Original Assignee
デヴィレックス アーゲー
デヴィレックス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デヴィレックス アーゲー, デヴィレックス アーゲー filed Critical デヴィレックス アーゲー
Publication of JP2013530208A publication Critical patent/JP2013530208A/ja
Publication of JP2013530208A5 publication Critical patent/JP2013530208A5/ja
Application granted granted Critical
Publication of JP5858994B2 publication Critical patent/JP5858994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013517583A 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 Active JP5858994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (3)

Publication Number Publication Date
JP2013530208A JP2013530208A (ja) 2013-07-25
JP2013530208A5 JP2013530208A5 (enExample) 2014-07-31
JP5858994B2 true JP5858994B2 (ja) 2016-02-10

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517583A Active JP5858994B2 (ja) 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
CN104994889B (zh) 2013-02-19 2017-04-26 强生消费者公司 用于改善疤痕组织的外观和形成的方法及组合物
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
WO2018095576A1 (en) * 2016-11-28 2018-05-31 Aicuris Anti-Infective Cures Gmbh Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide
AU2020268896B2 (en) 2019-05-03 2024-11-28 F. Hoffmann-La Roche Ag Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
KR20090111328A (ko) 2007-01-17 2009-10-26 데비렉스 아게 사이클로덱스트린 제형
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
AU2011275458A1 (en) 2013-02-28
IL223582A (en) 2017-12-31
JP2013530208A (ja) 2013-07-25
DK2563374T3 (da) 2014-01-20
EP2563374A1 (en) 2013-03-06
AU2011275458B2 (en) 2014-11-27
US20180055875A1 (en) 2018-03-01
HK1180969A1 (en) 2013-11-01
KR101881175B1 (ko) 2018-07-23
CN103079574A (zh) 2013-05-01
CN103079574B (zh) 2017-04-12
KR20130142992A (ko) 2013-12-30
US9814743B2 (en) 2017-11-14
ZA201300177B (en) 2014-03-26
RU2643763C2 (ru) 2018-02-05
US20130090389A1 (en) 2013-04-11
MX2012014783A (es) 2013-04-03
WO2012004669A1 (en) 2012-01-12
CA2803228C (en) 2019-03-12
CA2803228A1 (en) 2012-01-12
PT2563374E (pt) 2014-01-23
HRP20140135T1 (hr) 2014-03-28
PL2563374T3 (pl) 2014-04-30
EP2563374B1 (en) 2013-11-13
SI2563374T1 (sl) 2014-01-31
ES2442928T3 (es) 2014-02-14
RU2013100383A (ru) 2014-08-20
RS53162B (sr) 2014-06-30
SG186937A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
JP5858994B2 (ja) 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物
US20100111883A1 (en) Cyclodextrin formulations
Auvinet et al. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica
WO2017011785A1 (en) Topical antiviral formulations and methods of using the same
RU2251415C2 (ru) Синергетическое ингибирование вирусной репликации длинноцепочечными углеводородами и нуклеозидными аналогами
CN104853759A (zh) 以gpcr19作用剂作为有效成分的过敏性皮肤疾病的预防或治疗用组成物
JP3739098B2 (ja) 長鎖アルコール類、アルカン類、脂肪酸類およびアミド類によるウイルスの阻害
JP3180221B2 (ja) ヘルペス・シンプレックス・ウィルス感染治療用医薬組成物
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
ES2901389T3 (es) Aplicación de 4-[9-(6-aminopuril)]-2(s)-hidroxibutirato de metilo en la preparación de medicamentos para el tratamiento de la psoriasis y el vitíligo
WO2023202989A1 (en) Treatment of frontal fibrosing alopecia
JPH07118161A (ja) 抗ウイルス剤
EP2782585A1 (en) Antiviral formulations
JP2003292413A (ja) 皮膚外用剤
JPH09309831A (ja) 抗皮膚感覚異常剤
ITUB20159325A1 (it) Uso di un estratto o concentrato di gelso nero per la preparazione di prodotti cosmetici o integratori alimentari, e prodotti cosmetici o integratori alimentari cosi preparati

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20131118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20131118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150717

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151215

R150 Certificate of patent or registration of utility model

Ref document number: 5858994

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250